VALEANT PHARMACEUTICALS NORTH AMERICA LLC et al v. KVK-TECH, INC. > Documents
Date Field | Doc. No. | Description (Pages) |
---|---|---|
Nov 8, 2022 | 1 | Complaint* (1) |
Jul 15, 2019 | 11 | Order (2) Docket Text: ORDER Consolidating Civil Action No. 19-12845 and Civil Action No. 18-13635 for all purposes. It is ORDERED that all filings relating to Civil Action 19-12845 are to be made only in Civil Action 18-13635. Signed by Judge Peter G. Sheridan on 7/15/2019. (km) |
Jun 19, 2019 | 10 | Answer to Counterclaim (7) |
Jun 19, 2019 | 10 | Certificate of Service (2) |
Jun 19, 2019 | 10 | Main Document (7) Docket Text: ANSWER to Counterclaim by DOW PHARMACEUTICAL SCIENCES, INC., KAKEN PHARMACEUTICAL CO., LTD., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC. (Attachments: # (1) Certificate of Service)(DENI, WILLIAM) |
Jun 4, 2019 | 6 | Answer to Complaint (13) Docket Text:KVK-Tech, Inc.'s ANSWER to Complaint with Defenses and, COUNTERCLAIM against DOW PHARMACEUTICAL SCIENCES, INC., KAKEN PHARMACEUTICAL CO., LTD., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC by KVK-TECH, INC..(SLOCUM, CAROL) |
Jun 4, 2019 | 7 | Corporate Disclosure Statement (aty) (2) Docket Text: Corporate Disclosure Statement by KVK-TECH, INC.. (SLOCUM, CAROL) |
Jun 4, 2019 | 8 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by J. BRUGH LOWER on behalf of DOW PHARMACEUTICAL SCIENCES, INC., KAKEN PHARMACEUTICAL CO., LTD., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC (LOWER, J.) |
Jun 4, 2019 | 9 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE Returned Executed by DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD., KAKEN PHARMACEUTICAL CO., LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC. KVK-TECH, INC. waiver sent on 5/31/2019, answer due 7/30/2019. (LOWER, J.) |
May 23, 2019 | N/A | Add and Terminate Judges (0) Docket Text: Judge Peter G. Sheridan and Magistrate Judge Lois H. Goodman added. (jmh) |
May 23, 2019 | 1 | Complaint (9) |
May 23, 2019 | 1 | Exhibit A (18) |
May 23, 2019 | 1 | Civil Cover Sheet (1) |
May 23, 2019 | 1 | L. Civ. R. 11.2 Certification (2) |
May 23, 2019 | 2 | Corporate Disclosure Statement (aty) (1) Docket Text: Corporate Disclosure Statement by DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC identifying Bausch Health Companies Inc. as Corporate Parent.. (DENI, WILLIAM) |
May 23, 2019 | 3 | Corporate Disclosure Statement (aty) (1) Docket Text: Corporate Disclosure Statement by KAKEN PHARMACEUTICAL CO., LTD.. (DENI, WILLIAM) |
May 23, 2019 | 4 | AO120 Patent/Trademark Form (1) Docket Text: AO120 Patent Form filed. (jmh) |
May 23, 2019 | 5 | Summons Issued (2) Docket Text: SUMMONS ISSUED as to KVK-TECH, INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (jmh) |
May 23, 2019 | 1 | Main Document (9) Docket Text: COMPLAINT against KVK-TECH, INC. ( Filing and Admin fee $ 400 receipt number 0312-9690056), filed by VALEANT PHARMACEUTICALS NORTH AMERICA LLC, KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD.. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet, # (3) L. Civ. R. 11.2 Certification)(DENI, WILLIAM) |